About
What We Do
The AMR Industry Alliance brings the life sciences sector together to act on antimicrobial resistance and advocate for the wider changes industry cannot deliver alone.
Together, our members account for close to one third of the world supply of antibiotics used in human health.
We convene companies across the antibiotic life cycle, set and maintain a common manufacturing standard backed by independent certification, support the responsible use that keeps antibiotics working, and report on members’ contribution to the response. When the Alliance refers to antimicrobial products, it means diagnostics, generic antimicrobials, and novel medicines alike. Together, our members account for close to one third of the world supply of antibiotics used in human health.
We work through member working groups on access and appropriate use, manufacturing, and research and science. In each, members prepare positions, take them to governments and global institutions, and build the evidence base behind them. We take part in the forums where decisions are made, from the UN High-Level Meetings on AMR to the gatherings that shape global health policy. We advance the WHO Global Action Plan on AMR, the Sustainable Development Goals, and the UN Political Declaration on AMR. Resistance spans human and animal health, agriculture, and the environment, so we call for a One Health approach that brings governments, industry, academia, and civil society together.
The urgency is clear. Left unchecked, resistance could return us to a world where routine infections become untreatable again, and a century of medical progress erodes with it. No single company or country can hold that back alone. We exist so the life sciences sector can speak with one voice and press for what no member could secure alone, and we work with governments, health systems, and partners across the response to get there.
Get in touch
Whether you’re a member, a partner, or exploring how to engage,
we’d like to hear from you.